Growth of the pathogenic yeast Candida albicans in sub-MIC (minimum inhibitory concentration) levels of Cu(ClO 4 ) 2 · 6H 2 O and [Cu(phendio) 3 ](ClO 4 ) 2 · 4H 2 O (phendio = 1,10-phenanthroline-5,6-dione) increased the concentration of miconazole and amphotericin B required to achieve the MIC 90 whereas pre-growth in AgClO 4 and [Ag(phendio) 2 ]ClO 4 resulted in a small decrease in the relevant MIC 90 values. The copper complexes reduce the oxygen consumption of C. albicans while the silver complexes increase oxygen consumption. In addition, pregrowth of cells in the copper complexes resulted in a lower ergosterol content while the silver complexes induced an elevation in ergosterol synthesis.
Introduction
The yeast Candida albicans is responsible for a range of superficial and systemic diseases in the immunocompromised patient. Conventional therapies for the control of these diseases rely upon the use of azole and polyene drugs which target ergosterol biosynthesis and alter membrane permeability, respectively (White et al., 1998 , Abu Salah, 1996 . In recent years, the appearance of fungal strains manifesting resistance to conventional drugs (Canuto & Rodero, 2002) has prompted the search for novel anti-fungals with modes of action distinct to the existing range of anti-fungals.
Metal-based drugs represent a novel group of antifungal agents with potential applications for the control of fungal infections. Previous work in our laboratories has demonstrated that in RPMI medium at 37 o C the metal-based drugs [Cu(phen) 2 (mal)]·2H 2 O, [Mn(phen) 2 (mal)]·2H 2 O and [Ag(phen) 2 ]ClO 4 (phen = 1,10-phenanthroline) inhibit the growth of C. albicans by around 95% at a concentration of 5 µg/ml (McCann et al. 2000; Coyle et al. 2003a) . It was established that both metal-free phen and the metalphen complexes affect mitochondrial function, retard the synthesis of cytochromes b and c and uncouple respiration. Treatment of fungal cells with the Cu(II) and Ag(I) complexes resulted in a reduced amount of ergosterol in the cell membrane and subsequent increase in its permeability. Cells exposed to metal-free phen and the Cu(II) and Mn(II) complexes (but not the Ag(I) complex) demonstrated an elevation in oxygen uptake. The general conclusion was that the drugs damage mitochondrial function and uncouple respiration. Fur-thermore, the fact that the drugs were not uniformly active suggested that their bioactivity had a degree of metal-ion dependency.
More recently, metal-free phendio (phendio = 1,10-phenanthroline-5,6-dione) and the Ag(I) complex [Ag(phendio) 2 ]ClO 4 have been shown to cause extensive, non-specific DNA cleavage to C. albicans, disrupt cell division and induce gross distortions in fungal cell morphology (Coyle et al., 2003b) . Preliminary experiments on cultured human cancer cells produced IC 50 values of 0.008 µg/ml (0.04 µM) and 0.025 µg/ml (0.40 µM) for metal-free phendio and [Ag(phendio) 2 ]ClO 4 , respectively (Coyle et al. 2003b) . Studies by Igdaloff et al. (1983) revealed that both phendio and its isomer, 1,7-phenanthroline-5,6-dione, inhibit the growth of S49 mouse lymphona cells and S110 mouse cells, and although it was postulated that inhibition of DNA and RNA syntheses were major components of the cytotoxic effects the phenanthrolines were presumed to have more than one mode of action.
Metal-based drugs have well established fungistatic and fungicidal effects and the aim of the work presented here was to evaluate the possibility of using Cu (II) and Ag (I) phendio complexes in combination with azole and polyene drugs for the control of C. albicans. 
Materials and methods

Fungal
Anti-Candida susceptibility testing of metal-based drugs
Solutions of water-soluble copper and silver complexes were prepared by dissolving 0.02 g of the solid in sterile distilled water to yield a stock solution of 200 µg/ml. The solutions were filter sterilised using a Millipore membrane filter (0.45 µm). Stationary phase cultures of C. albicans were harvested by centrifugation (2220 × g for 5 min in a Beckmann GS-6 centrifuge), washed twice with PBS and resuspended at a final density of 1 × 10 6 cells/ml. Cell suspension (100 µl) was added to each well of a 96-well microtitre plate except the first column (control medium). Serial dilutions of metal-based drugs were added to rows of wells to construct a concentration gradient from 50-0.78 µg/ml and the plates were incubated at 30 • C for 24 h. The absorbance at 450 nm was determined using a MRX spectrophotometer (Dynax Technology, Chantilly, VA, USA) and the concentration that was capable of inhibiting growth by 90% (MIC 90 ) relative to the control was calculated.
Amphotericin B and miconazole susceptibility testing
Yeast cultures were grown to the stationary phase in antibiotic medium 3 (AB 3, Oxoid) overnight at 30 • C and 200 rpm, harvested by centrifugation and diluted to 1 × 10 6 /ml. Cells (1 × 10 5 in 100 µl) were added to each row of a 96-well plate containing amphotericin B in serial dilutions (Sigma-Aldrich) from 2.5-0.0048 µg/ml in AB3 medium.
Miconazole susceptibility testing was performed using stationary phase C. albicans that had been grown in RPMI medium overnight (Sigma Aldrich). Cells (100 µl of 1 × 10 6 /ml) were added to each row of a 96-well plate containing miconazole, serially diluted in RPMI medium from 20-0.19 µg/ml.
All plates were incubated at 30 • C for 24 h and the optical density was read at 450 nm using a MRX spectrophotometer (Dynax Technology, Chantilly, VA, USA).
Oxygen consumption
Cells were grown in YEPD broth supplemented with sub-MIC levels of silver or copper complexes at 30 • C for 24 h, harvested by centrifugation and re-suspended at a density of 1 × 10 8 /ml in phosphate buffered saline (PBS, pH 7.2). A Clark Type oxygen electrode (Ranks Brothers, Cambridge, UK) was employed to determine the respiration rate of cells. The rate of oxygen consumption is expressed as the number of µmoles of oxygen consumed per thirty sec per 1 × 10 8 cells.
Sterol extraction and analysis
Sterols were extracted according to the method of Arthington-Skaggs et al. (1999) . Stationary phase cells (1.3 g wet weight) were harvested and washed with PBS (pH 7.2). Cells were re-suspended in 20% (w/v) KOH and 60% (v/v) ethanol and placed in a shaking water bath (80-90 • C) for 1.5 h. Heptane was added to the solution which was then agitated for 10 sec and the aqueous layer removed. The sterol content of the hexane layer was quantified using a dual beam spectrophotometer over the range 250-300 nm.
Statistical analysis
The Kruskal-Wallis test was performed, where appropriate, on all results using the SigmaStat Statistical Analysis System (Version 1.00). Values are presented as ± SE of the mean of data from three independent experiments.
Results
The effect of selected Cu(II) and Ag(I) phendio complexes on the growth of C. albicans was assessed. The results indicate (Figure 1) O at concentrations of 12.5 µg/ml and 11.5 µg/ml, respectively. Sub-MIC values were employed in all subsequent assays so that any effect on drug susceptibility would not be due to the fungistatic effects of these compounds Experiments were performed to determine whether pre-growth of C. albicans in the presence of different metal complexes affected the subsequent susceptibility of cells to azole and/or polyene drugs. Cells were pre-grown in medium supplemented with 1/4 MIC 90 of the Cu(II) and Ag(I) phendio complexes for 24 h at 30 • C and harvested by centrifugation. Anti-fungal susceptibility assays were performed as described. The results (Figure 2 ) indicate that pre-growth of C. albicans in medium supplemented with 12.5 µg/ml Cu(ClO 4 ) 2 ·6H 2 O or 11.5 µg/ml [Cu(phendio) The susceptibility of C. albicans to the polyene drug amphotericin B was also affected following pre-growth of the cells in medium supplemented with copper or silver complexes at 1/4 MIC 90 values (Figure 3 ). In the case of pre-growth in 1/4 MIC 90 Cu(ClO 4 ) 2 ·6H 2 O the amount of amphotericin B required to achieve the MIC 90 increases to 0.029 ± 0.007 µg/ml from 0.024 ± 0.003 µg/ml (control) and following pre-growth in a similar concentration of [Cu(phendio) 3 ](ClO 4 ) 2 ·4H 2 O increases to 0.03 ± 0.003 µg/ml (p = 0.238). In the case of pre-exposure to the silver complexes there is a decrease in the amount of amphotericin B required to achieve the MIC 90 . Pre-growth of C. albicans in either of the silver complexes reduces the amount of amphotericin B required to achieve the MIC 90 from 0.024 ± 0.003 µg/ml to 0.019 ± 0.001 µg/ml (p = 0.238) (Figure 3) .
Azoles, such as miconazole, inhibit the action of lanosterol 14α-demethylase which controls an essential intermediate step in the biosynthesis of ergosterol (White et al., 1998 , Daum et al., 1998 . In contrast, polyenes, such as amphotericin B, bind to ergosterol in the fungal cell membrane creating pores through which cell constituents may escape (Abu Salah, 1996) . Ergosterol biosynthesis is an oxygen dependent process and also requires NADPH which is synthesised in the aerobically respiring mitochondrion. Consequently, experiments were performed to establish whether the altered susceptibility of C. albicans to miconazole and amphotericin B was due to the ability of the copper or silver complexes to alter respiration. The results (Figure 4) The ergosterol biosynthetic pathway is the target of the azole drugs (White et al. 1998 ) whilst polyenes bind ergosterol in the cell membrane and create pores (Abu Salah, 1996) . Quantification of ergosterol in cells grown in medium supplemented with sub MIC 90 concentrations of the metal-based drugs demonstrated that growth in the presence of copper complexes resulted in a reduced ergosterol content, while growth in medium supplemented with the silver complexes resulted in an increase in cellular ergosterol ( Figure 5) figure) . The relative amounts of ergosterol in cells pre-treated with sub-MIC 90 concentrations of metal-based drug were ascertained spectrophotometrically over the range 250-300 nm.
Discussion
Metal-based drugs represent a novel group of antimicrobial agents with potential therapeutic applications (Coyle et al. 2003a; McCann et al. 2000) . With the advent of fungal isolates manifesting resistance to azole and polyene drugs (Canuto & Rodero, 2002) there is a requirement for new drugs with alternative modes of action or with the ability to increase the efficacy of existing prescription drugs. Many metalbased drugs display modes of action distinct to those of the prescription anti-fungals (Coyle et al. 2003a) possibly allowing their use where resistance to conventional drugs has emerged (White et al. 1998 ). In addition, their different mode(s) of action may be utilised by employing such drugs in conjunction with existing drugs in order to target two (or more) sites within the fungal cell and thus raising the possibility of achieving the same therapeutic effect by reducing the required amount of an azole or polyene drug. Conventional anti-fungal drugs such as polyenes or azoles target ergosterol in the cell membrane or the ergosterol biosynthetic pathway, respectively. In the work presented here we have evaluated the ability of Cu(II) and Ag(I) phendio complexes to alter the susceptibility of C. albicans to conventional azole and polyene drugs.
The copper and silver complexes evaluated here demonstrated fungistatic properties but for this work sub-MIC 90 values were employed to ascertain their effect on the sensitivity of C. albicans to the conventional antifungal drugs. Sub-MIC levels were chosen to ensure that the observed effect was not due to the fungistatic actions of the metal complex. The alteration in susceptibility to miconazole and amphotericin B may occur due to the fact that the metal complexes which inhibit respiration (i.e. Cu(ClO 4 ) 2 ·6H 2 O and [Cu(phendio) 3 ](ClO 4 ) 2 ·4H 2 O) also cause a reduction in the cellular ergosterol content. Azoles, such as miconazole, target lanosterol 14α-demethylase which regulates an intermediate step in ergosterol biosynthesis (Morschhauser, 2002) . The azoles can kill cells by inhibiting this enzyme which subsequently leads to a decrease in ergosterol content of the fungal cell membrane. In addition, the inhibition of the action of 5,6 -sterol desaturase by fluconazole leads to the accumulation of toxic intermediates (such as 14α-methylfecosterol) which may prove fatal to the fungal cell (Geber et al. 1995) . The altered susceptibility to miconazole may be due to reduced ergosterol biosynthesis resulting in fewer toxic side products being formed once the action of the demethylase has been inhibited by miconazole. Enhanced ergosterol biosynthesis may inadvertently lead to greater production of toxic side-products once the azole-mediated inhibition of sterol biosynthesis occurs.
Reduced levels of ergosterol in the fungal cell membrane provide fewer binding sites for amphotericin B. Consequently a higher concentration of amphotericin B is required to retard the growth of the cell. Reductions in sterol levels in C. albicans have been identified previously as a mechanism for increased growth in the presence of amphotericin B (Kelly et al. 1997; White et al. 1998) . Disruptions of the genes in the ergosterol biosynthesis pathway cause a decrease in ergosterol in C. glabrata and an increase in drug tolerance, particularly to amphotericin B (Geber et al. 1995; Vazquez et al. 1996) . Inhibition of respiration in C. albicans by erythromycin leads to a drop in ergosterol and a concomitant increase in tolerance to amphotericin B . In addition, disruption of mitochondrial function leads to tolerance to amphotericin B due to depleted ergosterol synthesis (Geraghty & Kavanagh, 2003b) .
The requirement for a functional mitochondrion in ergosterol biosynthesis is well characterised and arises from the provision of NADPH for squalene dimerisation (Parks & Casey, 1995) . In addition, Erg1 encodes squalene epoxidase, which converts squalene to 2,3-oxidosqualene. This is an oxygen-dependent step, and in a cell with reduced respiration there would a consequent reduction in the synthesis of ergosterol (Daum et al. 1998) , thus leading to the reduced ergosterol content evident in cells exposed to the copper complexes.
An increase in respiration, as evident when cells are pre-grown in the presence of AgClO 4 and [Ag(phendio) 2 ]ClO 4 stimulates ergosterol production. Thus, there is more ergosterol for amphotericin B to bind and, as a consequence, lowering the amount of the polyene necessary for inhibition of cell growth. In the case of the altered sensitivity to miconazole, the silver complexes stimulate respiration and ergosterol biosynthesis and consequently may indirectly lead to the generation of more toxic side-products once the cells are exposed to miconazole.
The work presented here demonstrates that using sub-MIC levels of copper or silver dione complexes it is possible to alter the amount of an azole or polyene drug required to inhibit the growth of C. albicans. This effect appears to be mediated through alterations in the respiration rate of the cell, thereby influencing the amount of ergosterol synthesis. This opens the possibility of utilising, non-toxic levels of silver complexes to stimulate respiration and ergosterol production with a concomitant reduction in the amount of miconazole or amphotericin B required to achieve the relevant MIC 90 .
